My work focuses on advancing CRISPR-based gene editing technologies through mechanistic studies that improve precision, efficiency, and safety. I am particularly interested in developing therapeutic strategies for cancer by exploiting tumor-specific genetic vulnerabilities, characterizing the diversity of editing outcomes, and engineering platforms for targeted interventions. Additional areas include understanding CRISPR-induced splicing modulation, identifying novel genomic targets, and bridging fundamental biology with translational applications to create next-generation therapeutic platforms.